Nanobiotix S.A. (0QAV.L)

EUR 3.04

(3.06%)

Total Debt Summary of Nanobiotix S.A.

Nanobiotix S.A.'s latest annual total debt in 2023 was 45.48 Million EUR , down -4.9% from previous year.
Nanobiotix S.A.'s latest quarterly total debt in 2024 Q2 was 44.48 Million EUR , down 0.0% from previous quarter.
Nanobiotix S.A. reported annual total debt of 53.16 Million EUR in 2022, up 15.53% from previous year.
Nanobiotix S.A. reported annual total debt of 46.02 Million EUR in 2021, down -6.04% from previous year.
Nanobiotix S.A. reported quarterly total debt of 50.56 Million EUR for 2023 FY, down -4.9% from previous quarter.
Nanobiotix S.A. reported quarterly total debt of 49.36 Million EUR for 2023 Q4, down 0.0% from previous quarter.

Annual Total Debt Chart of Nanobiotix S.A. (2023 - 2012)

Historical Annual Total Debt of Nanobiotix S.A. (2023 - 2012)

Year	Total Debt	Total Debt Growth
2023	45.48 Million EUR	-4.9%
2022	53.16 Million EUR	15.53%
2021	46.02 Million EUR	-6.04%
2020	48.97 Million EUR	10.0%
2019	44.52 Million EUR	116.98%
2018	20.52 Million EUR	333.91%
2017	4.72 Million EUR	-16.55%
2016	5.66 Million EUR	23.17%
2015	4.6 Million EUR	98.07%
2014	2.32 Million EUR	110.0%
2013	1.1 Million EUR	0.0%
2012	- EUR	0.0%

Year	Total Debt	Total Debt Growth
2024 Q2	44.48 Million EUR	0.0%
2023 FY	50.56 Million EUR	-4.9%
2023 Q4	49.36 Million EUR	0.0%
2023 Q2	54 Million EUR	0.0%
2022 Q4	53.16 Million EUR	0.0%
2022 Q2	45.1 Million EUR	0.0%
2022 FY	53.16 Million EUR	15.53%
2021 FY	46.02 Million EUR	-6.04%
2021 Q4	46.02 Million EUR	0.0%
2021 Q2	50.71 Million EUR	0.0%
2020 Q2	51.83 Million EUR	0.0%
2020 FY	48.97 Million EUR	10.0%
2020 Q4	48.97 Million EUR	0.0%
2019 Q4	44.52 Million EUR	0.0%
2019 FY	44.52 Million EUR	116.98%
2019 Q2	44.07 Million EUR	0.0%
2018 FY	20.52 Million EUR	333.91%
2018 Q4	20.52 Million EUR	0.0%
2018 Q2	4.02 Million EUR	0.0%
2017 FY	4.72 Million EUR	-16.55%
2017 Q4	4.51 Million EUR	0.0%
2017 Q2	5.16 Million EUR	0.0%
2016 Q2	4.08 Million EUR	0.0%
2016 FY	5.66 Million EUR	23.17%
2016 Q4	5.66 Million EUR	0.0%
2015 Q4	4.6 Million EUR	0.0%
2015 Q2	4.66 Million EUR	0.0%
2015 FY	4.6 Million EUR	98.07%
2014 FY	2.32 Million EUR	110.0%
2014 Q4	2.32 Million EUR	0.0%
2014 Q2	1.33 Million EUR	0.0%
2013 FY	1.1 Million EUR	0.0%
2013 Q4	1.1 Million EUR	0.0%
2013 Q2	1.27 Million EUR	0.0%
2012 Q4	- EUR	0.0%
2012 Q3	- EUR	0.0%
2012 FY	- EUR	0.0%

Peer Total Debt Comparison of Nanobiotix S.A.

Name	Total Debt	Total Debt Difference
Boiron SA	13.7 Million EUR	-231.944%
Laboratorios Farmaceuticos Rovi, S.A.	46.63 Million EUR	2.47%
Vetoquinol SA	17.62 Million EUR	-158.016%
Valneva SE	208.81 Million EUR	78.219%
AB Science S.A.	19.1 Million EUR	-138.118%
PHAXIAM Therapeutics S.A.	10.19 Million EUR	-345.955%
Vivoryon Therapeutics N.V.	38 Thousand EUR	-119592.105%
BioSenic S.A.	28.16 Million EUR	-61.511%
ABIVAX Société Anonyme	55.46 Million EUR	17.995%
Formycon AG	29.48 Million EUR	-54.253%